SBIR/STTR Research Award
THEIR POTENTIAL APPLICATIONS TO A SUBUNIT VACCINE
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1986Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- NEUGENESIS CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
HUMAN T-CELL LYMPHOTROPHIC VIRUS TYPE I (HTLV-I) IS THE CAUSATIVE AGENT OF AN AGGRESSIVE FORM OF T-CELL LEUKEMIA ENDEMIC TO CERTAIN GEOGRAPHIC AREAS BUT ALSO CURRENTLY INCREASING IN FREQUENCY IN THE SAME POPULATION AT RISK FOR DEVELOPING AIDS. SERO-EPIDEMIOLOGIC DATA SUGGEST THE PRESENCE OF A TYPE-COMMON NEUTRALIZATION DETERMINANT. THIS PROPOSAL SEEKS TO IDENTIFY AND PRODUCE, BY USE OF A RECOMBINANT DNA EXPRESSION SYSTEM, HTLV-I ENCODED EPITOPES TO ASSESS THEIR EFFECT ON IN VITRO MEASURES OF INFECTIVITY AND VIRUS NEUTRALIZATION. IMMUNOREACTIVE EPITOPES CHARACTERIZED IN THIS MANNER HAVE POTENTIAL APPLICATION TO EVENTUAL PRODUCTION OF AN HTLV-I SUBUNIT VACCINE.
Technology keywords
Not reported